From the Sector

Absorbent hygiene products such as diapers, sanitary pads, and incontinence products are an integral part of our daily lives. However, most of these products contain synthetic components and contribute to the global plastic waste problem. The search for alternatives is becoming increasingly urgent. The catch is that only innovations that offer the same performance and reliability as conventional products can be successful in the market. After all, no one wants to compromise in such a sensitive area as personal hygiene.

Kelheim Fibres is currently working on various development projects to design fully biobased AHP (absorbent hygiene product) concepts that do not compromise on performance. In this area, the company continues to focus on its wood-based specialty fibres, which the tampon industry has trusted for decades. However, the requirements for AHP products differ, as each layer must fulfil a specific function.

To meet these requirements, Kelheim Fibres has developed a range of functionalized specialty fibres, including hydrophobic Olea, trilobal Galaxy®, and the hollow fibre Bramante. These specialty fibres ensure optimal results in every layer of the AHP product.

All of Kelheim's fibres are manufactured from 100% wood pulp derived from certified and sustainably managed forests. They are fully biodegradable - microorganisms in soil and seawater ensure that no residues remain.

A current example of such a partner project is the development of a completely bio-based panty liner with the nonwovens manufacturer Sandler and the hygiene products manufacturer pelzGROUP, which is due to be launched on the market shortly.

In addition to new projects in the field of biobased disposable and reusable solutions, Kelheim will also present its tried and tested fibres at INDEX™23, for example for tampons or flushable wipes.

Avgol®, a manufacturer of high-performance nonwoven fabric solutions, will use this month’s INDEXTM exhibition in Switzerland to showcase how it has a laser focus on delivering against sustainability objectives to safeguard the future.

Together with its sister companies from Indorama Ventures Limited (‘IVL’), Avgol will be presenting biotransformation capable fibers, spunbond, meltblown and SMS for diversified end-use markets at the event. Avgol will present and be available to discuss with visitors how this developing technology and the company’s other related products can help businesses achieve their 2030 sustainability goals.

Avgol will also highlight the latest solutions since recently announcing its collaboration with Algaeing™. Avgol uses patented algae bio-based formulations for colorants in its products, combining a unique environmental solution for modifying the aesthetic qualities of materials with Avgol’s ongoing commitment to sustainable polyolefin based spunbond and meltblown fabrics.

ExxonMobil will present its portfolio of products that enable innovative solutions with sustainability benefits for hygiene and personal care applications at INDEX™23. This portfolio includes ExxonMobil™ PP, Achieve™ Advanced PP (polypropylene) and Vistamaxx™ performance polymers that can be used to create differentiated hygiene and personal care products.

An innovation being presented will be the model baby diaper of which the chassis is made exclusively with ExxonMobil’s extensive portfolio of products. Also on display will be a new version of the high-loft, ultra-soft, silky-smooth nonwoven solution for premium hygiene products using a blend of Vistamaxx™ performance polymers, Achieve™ Advanced PP and ExxonMobil™ PP. Developed collaboratively with Reifenhäuser Reicofil, this nonwoven solution delivers sustainability benefits by including ExxonMobil™ PP ISCC PLUS mass balance certified circular polymers using Exxtend™ technology for advanced recycling of plastic waste. Produced efficiently in one step from pellet to nonwoven via high-speed spunbond process, this soft nonwoven is ideal for use in premium diapers, pant-type diapers, feminine care and adult incontinence products.

The diabetic community has always been a priority for Hologenix, creators of CELLIANT® infrared technology, so the company embarked on an initial study to test the hypothesis that the technology can positively impact diabetic patients with vascular impairment, now published in Journal of Textile Science & Engineering. Another study is underway as well with more research on the horizon.

According to statistics cited in the International Diabetes Federation Diabetes Atlas, 9th edition, globally, close to a half billion people are living with diabetes and that number is expected to increase by more than 50 percent in the next 25 years.
 
The introduction of the study in the Journal of Textile Science & Engineering also reports that diabetic patients frequently suffer from a combination of peripheral neuropathy and peripheral artery disease, which particularly affects their feet. It further states that it has been estimated that the lifetime risk for the development of foot ulcers in diabetic patients can be as high as 25 percent and that the risk of amputation is 10 to 20 times higher than in non-diabetic subjects.
 
The study was performed by Lawrence A. Lavery, D.P.M., M.P.H., a Professor in the Department of Plastic Surgery at UT Southwestern Medical Center. His clinic and research interests involve diabetic foot complications, infections and wound healing, and he participated in the conception, design, implementation and authorship of the Journal of Textile Science & Engineering study.  

CELLIANT technology is a patented process for adding micron-sized thermo-responsive mineral particles to fibers, in this case polyethylene terephthalate (PET) fibers. The resulting CELLIANT yarns were woven into stockings and gloves containing either 82% CELLIANT polyester, 13% nylon and 5% spandex or for the placebo, 82% polyester with no CELLIANT, 13% nylon and 5% spandex. CELLIANT products absorb body heat and re-emit the energy back to the body as infrared energy, which is non-invasive and increases temporary blood flow and cell oxygenation levels in the body.

The objective of the study was to “evaluate changes in transcutaneous oxygen (TcPO2) and peripheral blood flow (laser Doppler, LD) in the hands and feet of diabetic patients with vascular impairment when CELLIANT gloves and stockings are worn.” While there was not a statistically significant result across all subjects, the study did show that some patients wearing CELLIANT stockings for 60 minutes had an increase of as much as 20% in tissue oxygenation and 30% in localized blood flow. According to the study’s conclusion, “the trends that were observed in favor of CELLIANT stockings suggest that a larger well-designed clinical trial should be undertaken and may provide evidence of clinical efficacy in treatment of the diabetic foot.”
 
The study also notes that “There have been no documented or observed side effects of wearing CELLIANT stockings, and they are relatively inexpensive compared to conventional pharmaceutical interventions.”

Hologenix has embarked on a more comprehensive trial, “Study to Evaluate CELLIANT Diabetic Medical Socks to Increase Tissue Oxygenation and Incidence of Complete Wound Closure in Diabetic Foot Wounds” – NCT04709419, which focuses on the impact of CELLIANT technology to potentially improve tissue oxygenation and wound healing outcomes.
 
“We are excited to explore whether future studies of infrared, with its most common biological effects of increased localized blood flow and cellular oxygenation, could result in a breakthrough in diabetic patients with vascular impairment,” said Seth Casden, Hologenix Co-founder and CEO. “We see a huge potential opportunity with this research for helping to fulfill our core mission of improving people’s health and well-being by potentially reducing the impact of diabetes, and we are actively seeking partners to expand our research efforts.”

SHIMA SEIKI MFG., LTD. of Wakayama, Japan, together with its Hong Kong subsidiary SHIMA SEIKI (HONG KONG) LTD., will participate in the 40th Session of SPINEXPO in Shanghai, China from 12th - 14th April 2023.

At SPINEXPO, SHIMA SEIKI will offer visitors a choice between its "SDS®-ONE APEX4" apparel design system and its "APEXFiz®" subscription-based design software. Whereas SDS®-ONE APEX4 is offered as an all-in-one proprietary hardware + software package, APEXFiz® is subscription-based design software that can be installed on customers' individual computers. Both SDS®-ONE APEX4 and APEXFiz® software support the creative side of fashion from planning and design to colorway evaluation, realistic fabric simulation and 3D virtual sampling. Virtual samples are a digitized version of sample making that are accurate enough to be used effectively as prototypes, replacing physical sampling and consequently reducing time, cost and material that otherwise go to waste. When a design is approved for production, knitting data is automatically generated for converting to machine data, allowing smooth communication for digitally bridging the gap between studio and factory. APEXFiz® thereby helps to realize sustainability while digitally transforming the fashion supply chain.

Also on display at SPINEXPO will be SHIMA SEIKI's "yarnbank®," an online web service for searching and viewing the latest yarns, developed with cooperation from yarn companies from around the world. Registered users can download yarn data for free, for use in fabric simulation and virtual sampling on APEXFiz®, avoiding the need to scan yarn on their own. By using yarn that is used in actual production, designers and apparel companies can furthermore rest assured that the simulations created using yarn from yarnbank® are not merely realistic images but accurate representations using yarn that can actually be purchased and used in production. With yarnbank®, the entire supply chain from yarn companies and apparel companies to knit manufacturers can be connected digitally.

SHIMA SEIKI will also display the latest collection of its knit samples, including WHOLEGARMENT® knitwear that is knit in its entirety on the machine without the need for linking or sewing afterward. Together with virtual sampling performed on APEXFiz®, WHOLEGARMENT® offers smart production for realizing a sustainable fashion supply chain.

SABIC will present its portfolio of PURECARES™ and TRUCIRCLE™ materials for the healthcare and hygiene market at INDEX™23 from April 18 to 21 in Geneva, Switzerland, under the theme of ‘Collaborating for sustainability and innovative solutions’.

At INDEX, SABIC will highlight a joint project with two market leaders, using certified circular polymers from the TRUCIRCLE portfolio in recyclable films for feminine hygiene, baby care and disposable medical applications. In all of these cases from diapers to surgical drapes and medical gowns, the sustainable materials can serve as direct drop-in alternatives with no compromise in production efficiency and product performance.

Further examples on display at the company’s booth will feature TRUCIRCLE solutions for facemasks, including an N95 design that localizes the value chain with SABIC® PURECARES PP spunbond and meltblown polymers in Saudi Arabia. SABIC provides complete solutions for facemask production as part of its localization strategy and has been a key enabler of the Saudi Made initiative. Also shown will be a closed-loop facemask developed in collaboration with industrial and research partners in Europe.

The company’s PURECARES polyolefin products are based on technologies free of both tris (nonylphenyl) phosphite (TNPP) and phthalates. Consumer comfort is achieved by using SABIC polypropylene (PP) and polyethylene (PE) polymers for bi-component fibers to answer multiple needs for soft and loft handfeel nonwovens, enabling easy lamination to other building blocks on medical nonwovens or absorbent hygiene applications.

In addition, SABIC produces TRUCIRCLE certified circular polymers for its PURECARES PP and PE portfolio with feedstock based on advanced recycling of mixed and used plastic that would otherwise typically not be suitable for mechanical recycling processes. These more sustainable solutions can be adopted in downstream processes as direct drop-in alternatives to incumbent materials with no compromise in production efficiency, purity and product performance.

Paper Converting Machine Company (PCMC)—which specializes in the design and manufacture of high-performance converting machinery for the tissue, nonwovens, package-printing and bag-converting industries worldwide—announced that Windell McGill has joined the organization as the Product Launch Manager for its print business segment.

Bringing more than 25 years of print industry experience to PCMC, McGill will oversee product management, product launch and brand expansion for all PCMC print products and services.

Prior to joining PCMC, McGill was Managing Partner of ePac Atlanta, a provider of custom, high-quality flexible packaging solutions and digital printing services. Before that, he served as Business Segment Manager for flexible packaging at HP Indigo. McGill’s extensive experience also includes more than 15 years with Advanced Vision Technology, a provider of camera-based inspection equipment for the packaging market, where he held a variety of sales roles before being named President-Americas.

McGill will operate from his office in Atlanta.

• engelhorn zeigt sich farbenfroh im Frühling mit „Testa di Moro“

Anlässlich der BUGA 23 in Mannheim blüht es in den Häusern unter dem Motto „Testa di Moro“. Kundinnen und Kunden können seit knapp einer Woche die sizilianische, südländische Atmosphäre in den Häusern sehen und genießen. Die Schaufenster bei engelhorn Mode im Quadrat, engelhorn sports und engelhorn Dessous und Wäsche wurden vom Creative Director von engelhorn, Jürgen Müller, kunstvoll und aufwendig in Szene gesetzt. Zitronenbäume, Palmen, Olivenbäume und die sizilianische Keramiktradition bringen italienisches Flair nach Mannheim.

In Kooperation mit dem Künstler Antonio Fratantoni Ceramiche aus Santo Stefano di Camastra wird eine Auswahl der antiken Keramik präsentiert. Neben verschiedenen „Testa di Moro“-Köpfen, welche unter anderem liebevoll mit Zitronen, Blumen und Früchten gestaltet sind, finden Gäste über die Etagen hinweg kunstvolle Pinienzapfen, Vasen, bunte Schalen und Töpfe. Jedes Stück ist ein Unikat, das in Italien von Hand gefertigt wurde.

Der hauseigene Blumenstand i Fiori bei engelhorn Mode im Quadrat im Erdgeschoss zeigt sich ebenfalls farbenfroh und bringt italienisches Flair mit einer exklusiven, besonderen Blumenauswahl nach Hause. Olivenbäume, Zitronenbäume, Kakteen sowie mediterrane Kräuter werden neben der neusten Mode in Szene gesetzt und stehen zum Verkauf bereit.

The Swedish textile-to-textile recycling innovator Renewcell has signed a Letter of Intent with China Textile Academy Green Fibre Co. Ltd., an Chinese lyocell fiber producer, concerning a long-term commercial collaboration around man-made cellulosic fiber production.

The LOI provides the framework for an upcoming offtake agreement between the parties. The future legally binding offtake agreement will set out commercial terms for the delivery of 18,000 tonnes of Circulose® dissolving pulp to CTA Green Fibre over five years. CTA Green Fibre intends to use Circulose® as feedstock in the production of lyocell fibers to be supplied to textile manufacturers and fashion brands worldwide.

The agreement affirms the two companies’ intent to work together to supply lyocell textile fibers made using Circulose®, the 100% recycled textile pulp made by Renewcell, to global fashion brands in the coming years. The agreement has been facilitated by Ekman Group, Renewcell’s exclusive global trading partner.

Patrik Lundström, Renewcell’s CEO, commented: ”With this agreement, we take a new step in demonstrating the applicability of Circulose® in commercial-scale production of lyocell fibers. Lyocell is a high quality, low-impact fiber using closed loop production process which is highly sought after among our fashion brand partners that will now soon be available incorporating Circulose® recycled from textile waste. I am impressed by the innovative capacity and leadership of CTA Green Fibre and look forward to working together with them to make fashion circular together.”

Major developments FY 2022

• Currency-neutral revenues up 1% reflecting growth in all markets except Greater China
• Double-digit increases in North America and Latin America, EMEA up high single digits
• Gross margin declines to 47.3% due to strong increase in supply chain costs and discounting  
• Operating profit at € 669 million, including one-off costs of € 312 million
• Operating margin decreases to 3.0%  
• Net income (continuing operations) of € 254 million includes € 350 million one-off costs
• Executive and Supervisory Boards propose dividend of € 0.70 per share

Major developments Q4 2022

• Currency-neutral revenues decline 1% impacted by termination of Yeezy partnership
• Gross margin at 39.1% reflecting increased supply chain costs and higher discounting
• Operating loss of € 724 million
• Net loss from continuing operations of € 482 million

Outlook for 2023
Underlying operating profit expected to be around break-even level
In 2023, adidas expects currency-neutral revenues to decline at a high-single-digit rate as macroeconomic challenges and geopolitical tensions persist. Elevated recession risks in Europe and North America as well as uncertainty around the recovery in Greater China continue to exist. The company’s revenue development will also be impacted by the initiatives to significantly reduce high inventory levels. In addition, while the company continues to review future options for the utilization of its Yeezy inventory, the guidance already reflects the revenue loss of around € 1.2 billion from potentially not selling the existing stock. Accounting for the corresponding negative operating profit impact of around € 500 million, the company’s underlying operating profit is projected to be around the break-even level in 2023.

Reported operating loss of € 700 million projected
Should the company irrevocably decide not to repurpose any of the existing Yeezy product going forward, this would result in the potential write-off of the existing Yeezy inventory and would lower the company’s operating profit by an additional € 500 million this year. In addition, adidas expects one-off costs of up to € 200 million in 2023. These costs are part of a strategic review the company is currently conducting aimed at reigniting profitable growth as of 2024. If all these effects were to materialize, the company expects to report an operating loss of € 700 million in 2023.